首页|期刊导航|中医临床研究|中医药调控巨噬细胞极化治疗哮喘的研究进展

中医药调控巨噬细胞极化治疗哮喘的研究进展OA

A review on traditional Chinese medicine in treating asthma by regulating macrophage polarization

中文摘要英文摘要

支气管哮喘(简称哮喘)作为儿童时期最常见的呼吸系统疾病,患病率与发病率居高不下,现已成为影响人类健康及生活质量的重要问题.中医药治疗哮喘历史悠久,且在哮喘防治方面具有一定的优势,而巨噬细胞作为肺泡中最丰富的先天免疫细胞又与哮喘的发生发展密切相关.本研究系统梳理了 5年内中医药调控巨噬细胞极化干预治疗哮喘的相关研究,以期为今后深入探讨哮喘发病机制、阐释中医药防治机制提供思路及理论依据.

Bronchial asthma,the most prevalent respiratory disease in childhood,continues to persistently exhibit high morbidity and incidence rates,and emerges as a significant global health concern that impacts quality of life.Traditional Chinese medicine(TCM)has a well documented history in asthma treatment and demonstrates unique advantages in asthma's prevention and management.Notably,macrophages—the most abundant innate immune cells in alveoli—are closely implicated in asthma pathogenesis.This study systematically reviews recent 5-years advancements in TCM-based regulation of macrophage polarization for asthma management,aiming to provide insights and theoretical foundations for further exploration of asthma mechanisms and elucidation of TCM therapeutic principles.

王保团;牙库甫•亚森;阿合布•居马哈力

新疆科信职业技术学院,新疆 乌鲁木齐,830063新疆科信职业技术学院,新疆 乌鲁木齐,830063新疆科信职业技术学院,新疆 乌鲁木齐,830063

医药卫生

哮喘巨噬细胞极化中医药

AsthmaMacrophage polarizationTraditional Chinese medicine

《中医临床研究》 2026 (2)

54-58,5

10.3969/j.issn.1674-7860.2026.02.008

评论